Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

The apprehension of seronegative rheumatoid arthritis

Seronegative rheumatoid arthritis (RA) is often misunderstood and underrecognized, and this leads to delays in diagnosis and treatment. Emerging studies highlight distinct features and unmet needs of seronegative RA, calling for increased awareness of the challenges faced by patients and the need for tailored therapeutic approaches to improve outcomes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The long journey through apprehension and uncertainty for patients with seronegative RA compared to the less complicated path for patients with seropositive RA.

References

  1. Paroli, M. & Sirinian, M. I. When autoantibodies are missing: the challenge of seronegative rheumatoid arthritis. Antibodies 12, 69 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Myasoedova, E., Davis, J., Matteson, E. L. & Crowson, C. S. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014. Ann. Rheum. Dis. 79, 440–444 (2020).

    Article  PubMed  Google Scholar 

  3. Matthijssen, X. M. E., Huizinga, T. W. J. & van der Helm-van Mil, A. H. M. Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population. Ann. Rheum. Dis. 81, e69 (2022).

    Article  PubMed  Google Scholar 

  4. Soussi, B. G. et al. Incidence of seropositive and seronegative rheumatoid arthritis in Denmark: a nationwide population-based study. Scand. J. Rheumatol. 53, 316–324 (2024).

    Article  CAS  PubMed  Google Scholar 

  5. Muilu, P. et al. Increasing incidence and shifting profile of idiopathic inflammatory rheumatic diseases in adults during this millennium. Clin. Rheumatol. 38, 555–562 (2019).

    Article  PubMed  Google Scholar 

  6. Paalanen, K., Puolakka, K., Nikiphorou, E., Hannonen, P. & Sokka, T. Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study. Rheumatology 60, 2391–2395 (2021).

    Article  CAS  PubMed  Google Scholar 

  7. Paalanen, K. et al. Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study. Clin. Exp. Rheumatol. 37, 37–43 (2019).

    PubMed  Google Scholar 

  8. Barra, L. et al. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis. J. Rheumatol. 41, 2361–2369 (2014).

    Article  PubMed  Google Scholar 

  9. Matthijssen, X. M. E., Niemantsverdriet, E., Huizinga, T. W. J. & van der Helm-van Mil, A. H. M. Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: a longitudinal cohort study in the Netherlands. PLoS Med. 17, e1003296 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Coffey, C. M., Crowson, C. S., Myasoedova, E., Matteson, E. L. & Davis, J. M. 3rd. Evidence of diagnostic and treatment delay in seronegative rheumatoid arthritis: missing the window of opportunity. Mayo Clin. Proc. 94, 2241–2248 (2019).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cynthia S. Crowson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Javed, I., Crowson, C.S. The apprehension of seronegative rheumatoid arthritis. Nat Rev Rheumatol 21, 575–576 (2025). https://doi.org/10.1038/s41584-025-01289-8

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41584-025-01289-8

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing